Comparison of 2 treatment schemes to eradicate Helicobacter pylori Comparación de dos esquemas de tratamiento para erradicar Helicobacter pylori.
Author
dc.contributor.author
Hoffenberg,
Author
dc.contributor.author
Reyes Reyes, Consuelo
Author
dc.contributor.author
Contreras Contreras, Marlene Daniella
Author
dc.contributor.author
Giglio, S.
Author
dc.contributor.author
Ossa,
Author
dc.contributor.author
Weitz,
Admission date
dc.date.accessioned
2019-01-29T14:55:25Z
Available date
dc.date.available
2019-01-29T14:55:25Z
Publication date
dc.date.issued
1995
Cita de ítem
dc.identifier.citation
Revista médica de Chile, Volumen 123, Issue 2, 2018, Pages 185-191
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/161363
Abstract
dc.description.abstract
INTRODUCTION: Anti secretory drugs, antimicrobials and bismuth salts are used with variable success to eradicate Helicobacter pylori. AIM: To assess the effectiveness and rates of reinfection of two therapeutic modalities H pylori infection in adult patients with duodenal ulcer or non ulcer dyspepsia. METHODS: During upper gastrointestinal endoscopy, 5 antral and 2 fundic biopsies were obtained and sent for microbiological and anatomopathological study. Patients infected with Helicobacter pylori were randomly assigned to receive during two weeks omeprazole 20 mg od plus amoxicillin 500 mg tid (group A) or bismuth subsalicylate 260 mg bid, metronidazole 250 mg tid and amoxicillin 500 mg tid (group B). A new endoscopy with antral and fundic biopsies was performed to all patients four weeks after discontinuing treatment and six months later to those in whom H pylori was eradicated. RESULTS: Eighty patients (40 in each treatment group) completed the treatment and follow up. H pylori was er